204
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Friedelin, a novel inhibitor of CYP17A1 in prostate cancer from Cassia tora

ORCID Icon, ORCID Icon, , ORCID Icon, , & ORCID Icon show all
Pages 9695-9720 | Received 01 Aug 2022, Accepted 04 Nov 2022, Published online: 14 Nov 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bhavana R. Shivankar, Vishwambhar Vishnu Bhandare, Krati Joshi, Vishal S. Patil, Priyanka Shrikant Dhotare, Kailas Dasharath Sonawane & Sailaja Krishnamurty. Investigation of cathinone analogs targeting human dopamine transporter using molecular modeling. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now

Articles from other publishers (3)

Jacek Kędzierski, Marie-Christin Jäger, Sadaf Naeem, Alex Odermatt & Martin Smieško. (2024) In silico and in vitro assessment of drugs potentially causing adverse effects by inhibiting CYP17A1. Toxicology and Applied Pharmacology 486, pages 116945.
Crossref
Sonni Maurit Benu, Riga Riga & Lia Dewi Juliawaty. (2023) Chemical Constituents from the Leaves of Dischidia nummularia (Asclepiadaceae). Natural Product Sciences 29:4, pages 263-267.
Crossref
Beatrice Irungu, Erick Okari, Mary Nyangi, Sospeter Njeru & Lilian Koech. (2023) Potential of medicinal plants as antimalarial agents: a review of work done at Kenya Medical Research Institute. Frontiers in Pharmacology 14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.